Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Treating thalassemia major-related iron overload: the role of deferiprone.

Berdoukas V, Farmaki K, Carson S, Wood J, Coates T.

J Blood Med. 2012;3:119-29. doi: 10.2147/JBM.S27400.

2.

Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Aessopos A, Berdoukas V.

Mediterr J Hematol Infect Dis. 2009 Jul 18;1(1):e2009002. doi: 10.4084/MJHID.2009.002.

3.

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.

Ladis V, Chouliaras G, Berdoukas V, Moraitis P, Zannikos K, Berdoussi E, Kattamis C.

Eur J Haematol. 2010 Oct;85(4):335-44. doi: 10.1111/j.1600-0609.2010.01491.x.

4.

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.

Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V.

J Cardiovasc Magn Reson. 2009 Jun 28;11:20. doi: 10.1186/1532-429X-11-20.

5.

Supplemental Content

Support Center